Market

Viatris's SWOT analysis: generic drug maker faces sector headwinds, eyes growth

Viatris's SWOT analysis: generic drug maker faces sector headwinds, eyes growth
Read More

Related Posts

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 in stock

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 ...

Enanta Pharma chief product officer sells $30k in stock

Enanta Pharma chief product officer sells $30k in stock

Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock

Adaptive Biotechnologies CSO Robins sells $672,515 in A...

Treasury market logs worst weekly rout since April, in a bad sign for borrowers

Treasury market logs worst weekly rout since April, in ...

Two of Brazil’s nine central bank seats likely to be unfilled at January meeting, sources say

Two of Brazil’s nine central bank seats likely to be un...